{"disease":{"id":"advanced-gastric-or-gastroesophageal-junction-g-gej-adenocarcinoma","name":"advanced gastric or gastroesophageal junction g gej adenocarcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06939452","title":"A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":37,"lead_sponsor_name":"Yongxu Jia","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}